Press "esc" to clear
Go to Advanced Search

Showing results

3140 of 2566
  • Embargo expired:
    31-Jul-2018 10:30 AM EDT

Article ID: 697886

Two Novel Studies That Could Improve the Prevention and Treatment of Diabetes Announced at the 70th AACC Annual Scientific Meeting

American Association for Clinical Chemistry (AACC)

Researchers have developed a novel test that rapidly distinguishes between type 1 and type 2 diabetes. This new method and a second study revealing gaps in care for women with gestational diabetes were presented today at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo, and could improve treatment for patients with all diabetes types across the board.

Released:
26-Jul-2018 8:55 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    31-Jul-2018 10:30 AM EDT

Article ID: 697893

Findings That Vitamin D Could Alleviate Rheumatoid Arthritis Symptoms Presented at the 70th AACC Annual Scientific Meeting

American Association for Clinical Chemistry (AACC)

Scientists have discovered that in rheumatoid arthritis (RA) patients, lower levels of vitamin D are associated with increased disease severity. Their findings, announced today at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo, indicate that vitamin D supplementation could significantly improve quality of life for RA patients.

Released:
26-Jul-2018 8:55 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    31-Jul-2018 10:00 AM EDT

Article ID: 697901

AACC Announces 2018 Corporate Supporter Award Winners; Thanks Organizations for Their Invaluable Support

American Association for Clinical Chemistry (AACC)

AACC is pleased to announce the recipients of the AACC 2018 Top Corporate Supporter Awards. This year, AACC recognizes 47 different companies and organizations that generously support the association through sponsorships, advertising, and exhibiting. These significant contributions make it possible for AACC to improve patient care by fostering research, innovation, and professional excellence in the field of laboratory medicine.

Released:
26-Jul-2018 8:55 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    30-Jul-2018 5:30 PM EDT

Article ID: 697864

Breakthroughs in Portable Diagnostic Tests to Be Presented in a Special Competition at the 70th AACC Annual Scientific Meeting

American Association for Clinical Chemistry (AACC)

Today biotech innovators will present portable tests that could help more patients get accurate diagnoses in a competition to win AACC’s Disruptive Technology Award.

Released:
26-Jul-2018 8:55 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
logo-ortho-clinical-diagnostics-black.jpg

Article ID: 698275

VITROS® XT 7600 Integrated System from Ortho Clinical Diagnostics Receives CE Mark, Bringing Innovative New Approach to Clinical Lab Management

70th AACC Annual Scientific Meeting Press Program

Ortho Clinical Diagnostics’ VITROS® XT 7600 Integrated System received CE Mark. By combining Ortho’s proprietary dry slide technology with sophisticated digital imaging and the potential to perform two separate lab tests simultaneously, Ortho introduces digital chemistry to clinical lab management

Released:
30-Jul-2018 4:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698246

Sysmex Celebrates 50th Anniversary, Shares Plans for Innovative Technology to Equip Clinical Lab of the Future, at 2018 AACC

70th AACC Annual Scientific Meeting Press Program

Sysmex, one of the fastest growing providers of diagnostic hardware and software in the U.S., celebrates its 50th anniversary in booth number 1231 at this year’s annual meeting of the American Association for Clinical Chemistry (AACC). The company is also sharing its plans to equip the clinical laboratory of the future with innovative solutions in flow cytometry, urinalysis and hematology.

Released:
30-Jul-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698243

Diagnostics Product and Service Provider MedTest Dx Unveils New Corporate Name Reinforcing Its Integrated Model that Better Serves Customers

70th AACC Annual Scientific Meeting Press Program

MedTest Holdings, the solution provider of choice offering integrated products and services for decentralized clinical diagnostic testing, today announced the debut of its new corporate name—MedTest Dx—at the upcoming 2018 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting.

Released:
30-Jul-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Agazie.feature.jpg

Article ID: 698186

WVU Researchers Working to Stop Cancer-Growth Protein

West Virginia University

What do one in five breast cancers have in common? Large amounts of a protein called HER2 (or human epidermal growth factor receptor 2). “Every healthy cell produces a normal amount of HER2, but HER2 is produced 10 to 20 times more in a cancer cell,” said Yehenew Agazie, an associate professor of biochemistry at the West Virginia University School of Medicine.

Released:
30-Jul-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    29-Jul-2018 6:00 PM EDT

Article ID: 697860

Expanding the Boundaries of Genomic Detection, Cancer Therapies, Population Health, and Pain Treatment at the 70th AACC Annual Scientific Meeting

American Association for Clinical Chemistry (AACC)

At the 70th AACC Annual Scientific Meeting & Clinical Lab Expo—the premier global conference and exhibit for laboratory medicine—trailblazers in the field will share the pioneering research and technology paving the way for better clinical testing and patient care. From July 29–August 2 in Chicago, the meeting will feature more than 200 talks on a broad range of timely healthcare topics.

Released:
26-Jul-2018 8:55 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698198

PixCell Medical Presents the HemoScreen: Blood Testing at the Point of Care

70th AACC Annual Scientific Meeting Press Program

PixCell is a cell based diagnostics company that has developed the HemoScreen: the first true Point of Care (POC) Hematology analyzer that uses a self-contained disposable cartridge, preventing the need for any maintenance or calibrations. The HemoScreen is a portable and user-friendly test device that provides lab accurate results for the standard 20 Complete Blood Count (CBC) parameters, including a 5-part differential.

Released:
29-Jul-2018 4:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

3140 of 2566





Chat now!